Clinical Trials Browser

Has results × mirdametinib × 90 days × Clear all

NCT03962543 2026-05-06

ReNeu

Phase 2 Active not recruiting

114 enrolled 25 charts 1 FDA

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

NCT05580770 2026-05-01

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Phase 1/2 Terminated

23 enrolled 22 charts

Other solid neoplasm

Advanced Solid Tumor